Medical devices with direct or indirect patient contact are - for good reason - subject to strict rules for approval. It is therefore important particularly for SMEs to know whether their product is b
Services Dr. Nicole Schneiderhan-Marra Head of Pharma & Biotech +49 7121 51530-815 E-Mail anzeigen Dr. Markus Templin Group Leader Assay Development +49 7121 51530-828 E-Mail anzeigen Dr. Jens Göpfert
MIK - MDR- & IVDR-Competence Centre Dr. Hanna Hartmann Head of Biomedicine & Material Sciences +49 7121 51530-872 E-Mail anzeigen Dr. Xin Xiong Group Leader Biofunctionalized Surfaces +49 7121 51530-4
Media Library In our media library you will find our news archive, publications by our scientists, flyers on various topics, clips on our core competencies and the Paper Awards. NMI Best Paper Awards
Discover the future of biomedicine at the 3G-BioInk project meeting. Learn from leading minds about the latest advances funded by BMBF. At the second project meeting of the ambitious 3G-BioInk project
The development of biopharmaceutical products from the idea to the mature product is time-consuming and requires enormous resources. An essential part of the development of therapeutic antibodies, nan
Attend the prestigious Drug Discovery Summit in Basel and network with over 350 leaders in research biology and chemistry working on critical strategies for target identification, validation and HIT o
The aim of the Fiber4Ink project is to research a novel material platform for 3D bioprinting (a so-called bio-ink), which can be used to enable breakthrough innovations in the field of tissue engineer
Current Tenders For our tenders, the NMI uses the subreport ELViS award platform . There, we make all award documents available for download, in particular the specifications, the award criteria and f